BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25128009)

  • 1. Advancing regulatory science to bring novel medical devices for use in emergency care to market: the role of the Food and Drug Administration.
    Scully CG; Forrest S; Galeotti L; Schwartz SB; Strauss DG
    Ann Emerg Med; 2015 Apr; 65(4):400-3. PubMed ID: 25128009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1991 Oct; 56(197):51169-70. PubMed ID: 10115059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA's new regulatory paradigms for in vitro diagnostic devices.
    Robinowitz M; Gutman SI
    Cytotherapy; 1999; 1(4):353-7. PubMed ID: 20426566
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Center for Devices and Radiological health: an update.
    Donawa M
    Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe and effective medical devices--everyone's responsibility.
    Franke KA
    Gastroenterol Nurs; 1992 Apr; 14(5):245-8. PubMed ID: 1581379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safe Medical Devices Act of 1990--FDA. Notice.
    Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA's proposed regulatory approach to regulation of hematopoietic stem/progenitor cell products.
    Harvath L
    Cytotherapy; 1999; 1(4):358-9. PubMed ID: 20440912
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA proposes "regulatory science" initiatives.
    Nurse Educ; 2011; 36(2):75. PubMed ID: 21330898
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance for the emergency use of unapproved medical devices; availability--FDA. Notice.
    Fed Regist; 1985 Oct; 50(204):42866-7. PubMed ID: 10274027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing FDA's regulatory science through weight of evidence evaluations.
    Cormier JW
    J Contemp Health Law Policy; 2011; 28(1):1-22. PubMed ID: 22292318
    [No Abstract]   [Full Text] [Related]  

  • 15. Advertising and promotion of medical devices.
    Portnoy S
    J Health Law; 2006; 39(2):265-82. PubMed ID: 17002234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthopaedic joint devices: the FDA's short answers to your questions.
    Foy JR; Buch BD
    J Am Acad Orthop Surg; 2008; 16 Suppl 1():S123-8. PubMed ID: 18612007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No. 121.
    Thomadsen BR; Heaton HT; Jani SK; Masten JP; Napolitano ME; Ouhib Z; Reft CS; Rivard MJ; Robin TT; Subramanian M; Suleiman OH
    Med Phys; 2010 May; 37(5):2300-11. PubMed ID: 20527564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement, Reduction, and Replacement (3R) Strategies in Preclinical Testing of Medical Devices.
    Hampshire VA; Gilbert SH
    Toxicol Pathol; 2019 Apr; 47(3):329-338. PubMed ID: 30270765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device standards: the view from the FDA.
    Cangelosi RJ
    J Clin Eng; 1980; 5(1):9-12. PubMed ID: 10246341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ball is in Your Court: Agenda for Research to Advance the Science of Patient Preferences in the Regulatory Review of Medical DevicesĀ in the United States.
    Levitan B; Hauber AB; Damiano MG; Jaffe R; Christopher S
    Patient; 2017 Oct; 10(5):531-536. PubMed ID: 28831745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.